Original Research

Published on 01 Jul 2024

A novel vaccine construct against Zika virus fever: insights from epitope-based vaccine discovery through molecular modeling and immunoinformatics approaches

in Vaccines and Molecular Therapeutics

Metab Alharbi
Abdulrahman Alshammari
Jawza F. Alsabhan
Sami I. Alzarea
Talal Alshammari
Fawaz Alasmari
Abdullah F. Alasmari

Frontiers in Immunology

doi 10.3389/fimmu.2024.1426496

1,449 views

Correction

Published on 01 Jul 2024

Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

in Vaccines and Molecular Therapeutics

Vincent Pernin
Maria Meneghini
Alba Torija
Thomas Jouve
Arnaud Del Bello
Iván Sanz-Muñoz
Jose Maria Eiros
Laura Donadeu
Carol Polo
Francisco Morandeira

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447503

577 views

Original Research

Published on 01 Jul 2024

Immuno-informatics study identifies conserved T cell epitopes in non-structural proteins of Bluetongue virus serotypes: formulation of a computationally optimized next-generation broad-spectrum multi-epitope vaccine

in Vaccines and Molecular Therapeutics

Harish Babu Kolla
Mansi Dutt
Anuj Kumar
Roopa Hebbandi Nanjunadappa
Tobias Karakach
Karam Pal Singh
David Kelvin
Peter Paul Clement Mertens
Channakeshava Sokke Umeshappa

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424307

1,901 views

Original Research

Published on 28 Jun 2024

Essential role of pre-existing humoral immunity in TLR9-mediated type I IFN response to recombinant AAV vectors in human whole blood

in Vaccines and Molecular Therapeutics

Nada S. Alakhras
Christopher A. Moreland
Li Chin Wong
Priyam Raut
Sid Kamalakaran
Yi Wen
Robert W. Siegel
Laurent P. Malherbe

Frontiers in Immunology

doi 10.3389/fimmu.2024.1354055

1,630 views
1 citation

Correction

Published on 27 Jun 2024

Corrigendum: 1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines

in Vaccines and Molecular Therapeutics

Yohei Maki
Toshihiro Kushibiki
Tomoya Sano
Takunori Ogawa
Eri Komai
Shusaku Takahashi
Etsuko Kitagami
Yusuke Serizawa
Ryosuke Nagaoka
Shinya Yokomizo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446711

515 views

Original Research

Published on 27 Jun 2024

The mammosphere-derived epithelial cell secretome modulates neutrophil functions in the bovine model

in Vaccines and Molecular Therapeutics

Rebecca M. Harman
Anja Sipka
Kelly A. Oxford
Leane Oliveira
Lucas Huntimer
Daryl V. Nydam
Gerlinde R. Van de Walle

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367432

1,485 views

Review

Published on 26 Jun 2024

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments

in Vaccines and Molecular Therapeutics

Lisa Feldman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384249

2,883 views
3 citations

Original Research

Published on 26 Jun 2024

Integrated microbiome and metabolome analysis reveals that new insight into Radix pseudostellariae polysaccharide enhances PRRSV inactivated vaccine

in Vaccines and Molecular Therapeutics

Gaolin Xu
Zelong You
Yu Zheng
Qixian Feng
Shishi Luo
Lihui Xu
Songying Bao
Quanxi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1352018

1,525 views

Review

Published on 25 Jun 2024

Current status and future directions for the development of human papillomavirus vaccines

in Vaccines and Molecular Therapeutics

Rui Wang
Hongpeng Huang
Chulin Yu
Xuefeng Li
Yang Wang
Liangzhi Xie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1362770

3,564 views
4 citations

Original Research

Published on 21 Jun 2024

Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency

in Vaccines and Molecular Therapeutics

Yanli Song
Jiaolei Wang
Zhihui Yang
Qian He
Chunting Bao
Ying Xie
Yufang Sun
Shuyan Li
Yaru Quan
Huijie Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1406138

2,789 views

Original Research

Published on 21 Jun 2024

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

in Vaccines and Molecular Therapeutics

Ana Vieira Antão
Friederike Oltmanns
Anna Schmidt
Vera Viherlehto
Pascal Irrgang
Marie-Anne Rameix-Welti
Wibke Bayer
Dennis Lapuente
Matthias Tenbusch

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376395

1,843 views
1 citation

Original Research

Published on 20 Jun 2024

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies

in Vaccines and Molecular Therapeutics

Gaoussou Sanou
Taciana Manso
Konstantin Todorov
Véronique Giudicelli
Patrice Duroux
Sofia Kossida

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393839

2,122 views

Original Research

Published on 20 Jun 2024

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming

in Vaccines and Molecular Therapeutics

Brittany D. Williams
Debora Ferede
Hazem F. M. Abdelaal
Bryan J. Berube
Brendan K. Podell
Sasha E. Larsen
Susan L. Baldwin
Rhea N. Coler

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424374

1,292 views
1 citation

Original Research

Published on 19 Jun 2024

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model

in Vaccines and Molecular Therapeutics

Ada da Silva Matos
Isabela Ferreira Soares
Rodrigo Nunes Rodrigues-da-Silva
Cinthia Magalhães Rodolphi
Letusa Albrecht
Rafael Amaral Donassolo
Cesar Lopez-Camacho
Ana Paula Dinis Ano Bom
Patrícia Cristina da Costa Neves
Fernando de Paiva Conte

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392043

1,212 views

Perspective

Published on 14 Jun 2024

Vaccines for Streptococcus agalactiae: current status and future perspectives

in Vaccines and Molecular Therapeutics

João Matheus Sobral Pena
Pamella Silva Lannes-Costa
Prescilla Emy Nagao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430901

2,032 views
3 citations

Perspective

Published on 14 Jun 2024

Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective

in Vaccines and Molecular Therapeutics

Elizabeth González-Cueto
José de la Fuente
César López-Camacho

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384442

1,729 views
1 citation

Navigation group

Articles

A novel vaccine construct against Zika virus fever: insights from epitope-based vaccine discovery through molecular modeling and immunoinformatics approaches

Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept

Immuno-informatics study identifies conserved T cell epitopes in non-structural proteins of Bluetongue virus serotypes: formulation of a computationally optimized next-generation broad-spectrum multi-epitope vaccine

Essential role of pre-existing humoral immunity in TLR9-mediated type I IFN response to recombinant AAV vectors in human whole blood

Corrigendum: 1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines

The mammosphere-derived epithelial cell secretome modulates neutrophil functions in the bovine model

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments

Integrated microbiome and metabolome analysis reveals that new insight into Radix pseudostellariae polysaccharide enhances PRRSV inactivated vaccine

Current status and future directions for the development of human papillomavirus vaccines

Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

IMGT/mAb-KG: the knowledge graph for therapeutic monoclonal antibodies

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming

Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model

Vaccines for Streptococcus agalactiae: current status and future perspectives

Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective